Gilead Sciences (GILD) Non-Current Deffered Revenue (2009 - 2013)

Gilead Sciences (GILD) has reported Non-Current Deffered Revenue for 5 consecutive years, with $22.0 million the latest figure, recorded in Q4 2013.

• Non-Current Deffered Revenue for Q4 2013 came in at $22.0 million, up 7.05% year-over-year; the trailing twelve-month figure through Dec 2013 was $22.0 million (up 7.05% YoY), and the FY2013 annual result was $22.0 million, up 7.05% from the prior year.
• Non-Current Deffered Revenue was $22.0 million for Q4 2013 at Gilead Sciences, down from $25.4 million in the prior quarter.
• Over five years, Non-Current Deffered Revenue peaked at $53.4 million in Q2 2009 and troughed at $20.5 million in Q4 2012.
• Average Non-Current Deffered Revenue over 5 years is $32.2 million, with a median of $31.1 million recorded in 2011.
• Year-over-year, Non-Current Deffered Revenue tumbled 39.96% in 2012 and rose 21.89% in 2013.
• Over 5 years, Non-Current Deffered Revenue stood at $43.0 million in 2009, then dropped by 23.66% to $32.8 million in 2010, then dropped by 2.97% to $31.9 million in 2011, then sank by 35.58% to $20.5 million in 2012, then grew by 7.05% to $22.0 million in 2013.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $22.0 million in Q4 2013, $25.4 million in Q3 2013, and $28.8 million in Q2 2013.